nodes	percent_of_prediction	percent_of_DWPC	metapath
Repaglinide—ALB—Estropipate—osteoporosis	0.107	0.154	CbGbCtD
Repaglinide—SLCO1B1—Conjugated Estrogens—osteoporosis	0.0925	0.133	CbGbCtD
Repaglinide—SLCO1B1—Estradiol—osteoporosis	0.0812	0.117	CbGbCtD
Repaglinide—CYP2C8—Raloxifene—osteoporosis	0.0552	0.0793	CbGbCtD
Repaglinide—CYP2C8—Ethinyl Estradiol—osteoporosis	0.0533	0.0766	CbGbCtD
Repaglinide—ALB—Estradiol—osteoporosis	0.0445	0.0639	CbGbCtD
Repaglinide—CYP2C8—Cholecalciferol—osteoporosis	0.0426	0.0613	CbGbCtD
Repaglinide—CYP2C8—Estradiol—osteoporosis	0.0344	0.0494	CbGbCtD
Repaglinide—CYP3A4—Estropipate—osteoporosis	0.0336	0.0482	CbGbCtD
Repaglinide—CYP3A4—Calcitriol—osteoporosis	0.0336	0.0482	CbGbCtD
Repaglinide—CYP3A4—Ergocalciferol—osteoporosis	0.0268	0.0386	CbGbCtD
Repaglinide—CYP3A4—Raloxifene—osteoporosis	0.0224	0.0322	CbGbCtD
Repaglinide—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0216	0.0311	CbGbCtD
Repaglinide—CYP3A4—Cholecalciferol—osteoporosis	0.0173	0.0248	CbGbCtD
Repaglinide—CYP3A4—Conjugated Estrogens—osteoporosis	0.0159	0.0228	CbGbCtD
Repaglinide—CYP3A4—Estradiol—osteoporosis	0.0139	0.02	CbGbCtD
Repaglinide—Skin disorder—Calcitriol—osteoporosis	0.000551	0.00241	CcSEcCtD
Repaglinide—Pancreatitis—Estradiol—osteoporosis	0.000551	0.00241	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Estropipate—osteoporosis	0.000551	0.00241	CcSEcCtD
Repaglinide—Eye disorder—Zoledronate—osteoporosis	0.000545	0.00239	CcSEcCtD
Repaglinide—Paraesthesia—Estropipate—osteoporosis	0.000543	0.00237	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Alendronate—osteoporosis	0.000542	0.00237	CcSEcCtD
Repaglinide—Cardiac disorder—Zoledronate—osteoporosis	0.000542	0.00237	CcSEcCtD
Repaglinide—Visual impairment—Conjugated Estrogens—osteoporosis	0.000542	0.00237	CcSEcCtD
Repaglinide—Bronchitis—Estradiol—osteoporosis	0.00054	0.00236	CcSEcCtD
Repaglinide—Back pain—Pamidronate—osteoporosis	0.000538	0.00235	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.000533	0.00233	CcSEcCtD
Repaglinide—Dyspepsia—Estropipate—osteoporosis	0.000532	0.00233	CcSEcCtD
Repaglinide—Erythema multiforme—Conjugated Estrogens—osteoporosis	0.000531	0.00232	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.000528	0.00231	CcSEcCtD
Repaglinide—Immune system disorder—Zoledronate—osteoporosis	0.000527	0.00231	CcSEcCtD
Repaglinide—Eye disorder—Conjugated Estrogens—osteoporosis	0.000525	0.0023	CcSEcCtD
Repaglinide—Dyspepsia—Alendronate—osteoporosis	0.000524	0.00229	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Estropipate—osteoporosis	0.000522	0.00228	CcSEcCtD
Repaglinide—Cardiac disorder—Conjugated Estrogens—osteoporosis	0.000522	0.00228	CcSEcCtD
Repaglinide—Arrhythmia—Zoledronate—osteoporosis	0.000521	0.00228	CcSEcCtD
Repaglinide—Paraesthesia—Ibandronate—osteoporosis	0.00052	0.00228	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.000517	0.00226	CcSEcCtD
Repaglinide—Constipation—Estropipate—osteoporosis	0.000517	0.00226	CcSEcCtD
Repaglinide—Alopecia—Zoledronate—osteoporosis	0.000516	0.00226	CcSEcCtD
Repaglinide—Dyspepsia—Raloxifene—osteoporosis	0.000515	0.00225	CcSEcCtD
Repaglinide—Hypersensitivity—Etidronic acid—osteoporosis	0.000515	0.00225	CcSEcCtD
Repaglinide—Dyspepsia—Ibandronate—osteoporosis	0.00051	0.00223	CcSEcCtD
Repaglinide—Constipation—Alendronate—osteoporosis	0.000509	0.00223	CcSEcCtD
Repaglinide—Malnutrition—Zoledronate—osteoporosis	0.000508	0.00222	CcSEcCtD
Repaglinide—Erythema—Zoledronate—osteoporosis	0.000508	0.00222	CcSEcCtD
Repaglinide—Immune system disorder—Conjugated Estrogens—osteoporosis	0.000508	0.00222	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.000507	0.00222	CcSEcCtD
Repaglinide—Hyperglycaemia—Estradiol—osteoporosis	0.000507	0.00222	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000505	0.00221	CcSEcCtD
Repaglinide—Hypertension—Risedronate—osteoporosis	0.000505	0.00221	CcSEcCtD
Repaglinide—Arrhythmia—Conjugated Estrogens—osteoporosis	0.000502	0.0022	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Ibandronate—osteoporosis	0.0005	0.00219	CcSEcCtD
Repaglinide—Arthralgia—Risedronate—osteoporosis	0.000498	0.00218	CcSEcCtD
Repaglinide—Chest pain—Risedronate—osteoporosis	0.000498	0.00218	CcSEcCtD
Repaglinide—Leukopenia—Pamidronate—osteoporosis	0.000498	0.00218	CcSEcCtD
Repaglinide—Alopecia—Conjugated Estrogens—osteoporosis	0.000497	0.00217	CcSEcCtD
Repaglinide—Constipation—Ibandronate—osteoporosis	0.000496	0.00217	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000495	0.00216	CcSEcCtD
Repaglinide—Pruritus—Etidronic acid—osteoporosis	0.000494	0.00216	CcSEcCtD
Repaglinide—Gastrointestinal pain—Estropipate—osteoporosis	0.000494	0.00216	CcSEcCtD
Repaglinide—Acute coronary syndrome—Estradiol—osteoporosis	0.000494	0.00216	CcSEcCtD
Repaglinide—Back pain—Zoledronate—osteoporosis	0.000491	0.00215	CcSEcCtD
Repaglinide—Myocardial infarction—Estradiol—osteoporosis	0.000491	0.00215	CcSEcCtD
Repaglinide—Oedema—Ethinyl Estradiol—osteoporosis	0.00049	0.00214	CcSEcCtD
Repaglinide—Erythema—Conjugated Estrogens—osteoporosis	0.000489	0.00214	CcSEcCtD
Repaglinide—Malnutrition—Conjugated Estrogens—osteoporosis	0.000489	0.00214	CcSEcCtD
Repaglinide—Jaundice—Estradiol—osteoporosis	0.000488	0.00214	CcSEcCtD
Repaglinide—Urinary tract infection—Estradiol—osteoporosis	0.000487	0.00213	CcSEcCtD
Repaglinide—Gastrointestinal pain—Alendronate—osteoporosis	0.000487	0.00213	CcSEcCtD
Repaglinide—Constipation—Calcitriol—osteoporosis	0.000485	0.00212	CcSEcCtD
Repaglinide—Hypertension—Pamidronate—osteoporosis	0.00048	0.0021	CcSEcCtD
Repaglinide—Urticaria—Estropipate—osteoporosis	0.00048	0.0021	CcSEcCtD
Repaglinide—Gastrointestinal pain—Raloxifene—osteoporosis	0.000479	0.00209	CcSEcCtD
Repaglinide—Diarrhoea—Etidronic acid—osteoporosis	0.000478	0.00209	CcSEcCtD
Repaglinide—Abdominal pain—Estropipate—osteoporosis	0.000478	0.00209	CcSEcCtD
Repaglinide—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000476	0.00208	CcSEcCtD
Repaglinide—Hepatobiliary disease—Estradiol—osteoporosis	0.000474	0.00207	CcSEcCtD
Repaglinide—Gastrointestinal pain—Ibandronate—osteoporosis	0.000474	0.00207	CcSEcCtD
Repaglinide—Arthralgia—Pamidronate—osteoporosis	0.000474	0.00207	CcSEcCtD
Repaglinide—Back pain—Conjugated Estrogens—osteoporosis	0.000473	0.00207	CcSEcCtD
Repaglinide—Urticaria—Alendronate—osteoporosis	0.000473	0.00207	CcSEcCtD
Repaglinide—Abdominal pain—Alendronate—osteoporosis	0.00047	0.00206	CcSEcCtD
Repaglinide—Sinusitis—Estradiol—osteoporosis	0.00047	0.00206	CcSEcCtD
Repaglinide—Skin disorder—Risedronate—osteoporosis	0.000464	0.00203	CcSEcCtD
Repaglinide—Gastrointestinal pain—Calcitriol—osteoporosis	0.000464	0.00203	CcSEcCtD
Repaglinide—Abdominal pain—Raloxifene—osteoporosis	0.000463	0.00202	CcSEcCtD
Repaglinide—Urticaria—Ibandronate—osteoporosis	0.00046	0.00201	CcSEcCtD
Repaglinide—Abdominal pain—Ibandronate—osteoporosis	0.000458	0.002	CcSEcCtD
Repaglinide—Leukopenia—Zoledronate—osteoporosis	0.000455	0.00199	CcSEcCtD
Repaglinide—Anaphylactic shock—Pamidronate—osteoporosis	0.000454	0.00199	CcSEcCtD
Repaglinide—Oedema—Pamidronate—osteoporosis	0.000454	0.00199	CcSEcCtD
Repaglinide—Rhinitis—Estradiol—osteoporosis	0.000451	0.00197	CcSEcCtD
Repaglinide—Urticaria—Calcitriol—osteoporosis	0.000451	0.00197	CcSEcCtD
Repaglinide—Hepatitis—Estradiol—osteoporosis	0.00045	0.00197	CcSEcCtD
Repaglinide—Palpitations—Zoledronate—osteoporosis	0.000449	0.00196	CcSEcCtD
Repaglinide—Abdominal pain—Calcitriol—osteoporosis	0.000448	0.00196	CcSEcCtD
Repaglinide—Hypersensitivity—Estropipate—osteoporosis	0.000445	0.00195	CcSEcCtD
Repaglinide—Thrombocytopenia—Pamidronate—osteoporosis	0.000444	0.00194	CcSEcCtD
Repaglinide—Vomiting—Etidronic acid—osteoporosis	0.000444	0.00194	CcSEcCtD
Repaglinide—Oedema peripheral—Estradiol—osteoporosis	0.000443	0.00194	CcSEcCtD
Repaglinide—Rash—Etidronic acid—osteoporosis	0.00044	0.00193	CcSEcCtD
Repaglinide—Dermatitis—Etidronic acid—osteoporosis	0.00044	0.00192	CcSEcCtD
Repaglinide—Hypertension—Zoledronate—osteoporosis	0.000439	0.00192	CcSEcCtD
Repaglinide—Hypersensitivity—Alendronate—osteoporosis	0.000438	0.00192	CcSEcCtD
Repaglinide—Headache—Etidronic acid—osteoporosis	0.000438	0.00191	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000435	0.0019	CcSEcCtD
Repaglinide—Visual impairment—Estradiol—osteoporosis	0.000433	0.0019	CcSEcCtD
Repaglinide—Arthralgia—Zoledronate—osteoporosis	0.000433	0.00189	CcSEcCtD
Repaglinide—Chest pain—Zoledronate—osteoporosis	0.000433	0.00189	CcSEcCtD
Repaglinide—Palpitations—Conjugated Estrogens—osteoporosis	0.000432	0.00189	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.00043	0.00188	CcSEcCtD
Repaglinide—Paraesthesia—Risedronate—osteoporosis	0.000429	0.00188	CcSEcCtD
Repaglinide—Pruritus—Estropipate—osteoporosis	0.000428	0.00187	CcSEcCtD
Repaglinide—Hypersensitivity—Ibandronate—osteoporosis	0.000427	0.00187	CcSEcCtD
Repaglinide—Erythema multiforme—Estradiol—osteoporosis	0.000425	0.00186	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000423	0.00185	CcSEcCtD
Repaglinide—Pruritus—Alendronate—osteoporosis	0.000421	0.00184	CcSEcCtD
Repaglinide—Dyspepsia—Risedronate—osteoporosis	0.00042	0.00184	CcSEcCtD
Repaglinide—Eye disorder—Estradiol—osteoporosis	0.00042	0.00184	CcSEcCtD
Repaglinide—Constipation—Ethinyl Estradiol—osteoporosis	0.000419	0.00183	CcSEcCtD
Repaglinide—Hypersensitivity—Calcitriol—osteoporosis	0.000418	0.00183	CcSEcCtD
Repaglinide—Cardiac disorder—Estradiol—osteoporosis	0.000417	0.00183	CcSEcCtD
Repaglinide—Arthralgia—Conjugated Estrogens—osteoporosis	0.000417	0.00182	CcSEcCtD
Repaglinide—Chest pain—Conjugated Estrogens—osteoporosis	0.000417	0.00182	CcSEcCtD
Repaglinide—Nausea—Etidronic acid—osteoporosis	0.000415	0.00182	CcSEcCtD
Repaglinide—Oedema—Zoledronate—osteoporosis	0.000415	0.00181	CcSEcCtD
Repaglinide—Anaphylactic shock—Zoledronate—osteoporosis	0.000415	0.00181	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000414	0.00181	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000414	0.00181	CcSEcCtD
Repaglinide—Diarrhoea—Estropipate—osteoporosis	0.000413	0.00181	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Risedronate—osteoporosis	0.000412	0.0018	CcSEcCtD
Repaglinide—Pruritus—Ibandronate—osteoporosis	0.00041	0.00179	CcSEcCtD
Repaglinide—Constipation—Risedronate—osteoporosis	0.000408	0.00179	CcSEcCtD
Repaglinide—Paraesthesia—Pamidronate—osteoporosis	0.000408	0.00178	CcSEcCtD
Repaglinide—Diarrhoea—Alendronate—osteoporosis	0.000407	0.00178	CcSEcCtD
Repaglinide—Immune system disorder—Estradiol—osteoporosis	0.000406	0.00178	CcSEcCtD
Repaglinide—Thrombocytopenia—Zoledronate—osteoporosis	0.000406	0.00178	CcSEcCtD
Repaglinide—Skin disorder—Zoledronate—osteoporosis	0.000403	0.00176	CcSEcCtD
Repaglinide—Pruritus—Calcitriol—osteoporosis	0.000401	0.00176	CcSEcCtD
Repaglinide—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000401	0.00175	CcSEcCtD
Repaglinide—Diarrhoea—Raloxifene—osteoporosis	0.0004	0.00175	CcSEcCtD
Repaglinide—Dyspepsia—Pamidronate—osteoporosis	0.0004	0.00175	CcSEcCtD
Repaglinide—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000399	0.00175	CcSEcCtD
Repaglinide—Oedema—Conjugated Estrogens—osteoporosis	0.000399	0.00175	CcSEcCtD
Repaglinide—Alopecia—Estradiol—osteoporosis	0.000397	0.00174	CcSEcCtD
Repaglinide—Diarrhoea—Ibandronate—osteoporosis	0.000396	0.00173	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000392	0.00171	CcSEcCtD
Repaglinide—Erythema—Estradiol—osteoporosis	0.000392	0.00171	CcSEcCtD
Repaglinide—Malnutrition—Estradiol—osteoporosis	0.000392	0.00171	CcSEcCtD
Repaglinide—Gastrointestinal pain—Risedronate—osteoporosis	0.00039	0.00171	CcSEcCtD
Repaglinide—Urticaria—Ethinyl Estradiol—osteoporosis	0.000389	0.0017	CcSEcCtD
Repaglinide—Constipation—Pamidronate—osteoporosis	0.000388	0.0017	CcSEcCtD
Repaglinide—Diarrhoea—Calcitriol—osteoporosis	0.000388	0.0017	CcSEcCtD
Repaglinide—Skin disorder—Conjugated Estrogens—osteoporosis	0.000388	0.0017	CcSEcCtD
Repaglinide—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000387	0.00169	CcSEcCtD
Repaglinide—Vomiting—Estropipate—osteoporosis	0.000384	0.00168	CcSEcCtD
Repaglinide—Rash—Estropipate—osteoporosis	0.000381	0.00167	CcSEcCtD
Repaglinide—Dermatitis—Estropipate—osteoporosis	0.000381	0.00167	CcSEcCtD
Repaglinide—Urticaria—Risedronate—osteoporosis	0.000379	0.00166	CcSEcCtD
Repaglinide—Back pain—Estradiol—osteoporosis	0.000379	0.00166	CcSEcCtD
Repaglinide—Headache—Estropipate—osteoporosis	0.000379	0.00166	CcSEcCtD
Repaglinide—Vomiting—Alendronate—osteoporosis	0.000378	0.00166	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000378	0.00165	CcSEcCtD
Repaglinide—Abdominal pain—Risedronate—osteoporosis	0.000378	0.00165	CcSEcCtD
Repaglinide—Rash—Alendronate—osteoporosis	0.000375	0.00164	CcSEcCtD
Repaglinide—Dermatitis—Alendronate—osteoporosis	0.000375	0.00164	CcSEcCtD
Repaglinide—Headache—Alendronate—osteoporosis	0.000373	0.00163	CcSEcCtD
Repaglinide—Paraesthesia—Zoledronate—osteoporosis	0.000372	0.00163	CcSEcCtD
Repaglinide—Vomiting—Raloxifene—osteoporosis	0.000372	0.00163	CcSEcCtD
Repaglinide—Gastrointestinal pain—Pamidronate—osteoporosis	0.000371	0.00162	CcSEcCtD
Repaglinide—Rash—Raloxifene—osteoporosis	0.000369	0.00161	CcSEcCtD
Repaglinide—Dermatitis—Raloxifene—osteoporosis	0.000369	0.00161	CcSEcCtD
Repaglinide—Vomiting—Ibandronate—osteoporosis	0.000368	0.00161	CcSEcCtD
Repaglinide—Headache—Raloxifene—osteoporosis	0.000367	0.0016	CcSEcCtD
Repaglinide—Rash—Ibandronate—osteoporosis	0.000365	0.0016	CcSEcCtD
Repaglinide—Dermatitis—Ibandronate—osteoporosis	0.000365	0.0016	CcSEcCtD
Repaglinide—Dyspepsia—Zoledronate—osteoporosis	0.000365	0.0016	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000364	0.00159	CcSEcCtD
Repaglinide—Headache—Ibandronate—osteoporosis	0.000363	0.00159	CcSEcCtD
Repaglinide—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000361	0.00158	CcSEcCtD
Repaglinide—Vomiting—Calcitriol—osteoporosis	0.000361	0.00158	CcSEcCtD
Repaglinide—Nausea—Estropipate—osteoporosis	0.000359	0.00157	CcSEcCtD
Repaglinide—Abdominal pain—Pamidronate—osteoporosis	0.000359	0.00157	CcSEcCtD
Repaglinide—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000359	0.00157	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000358	0.00157	CcSEcCtD
Repaglinide—Rash—Calcitriol—osteoporosis	0.000358	0.00156	CcSEcCtD
Repaglinide—Dermatitis—Calcitriol—osteoporosis	0.000357	0.00156	CcSEcCtD
Repaglinide—Headache—Calcitriol—osteoporosis	0.000355	0.00155	CcSEcCtD
Repaglinide—Constipation—Zoledronate—osteoporosis	0.000355	0.00155	CcSEcCtD
Repaglinide—Nausea—Alendronate—osteoporosis	0.000354	0.00155	CcSEcCtD
Repaglinide—Hypersensitivity—Risedronate—osteoporosis	0.000352	0.00154	CcSEcCtD
Repaglinide—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000351	0.00154	CcSEcCtD
Repaglinide—Nausea—Raloxifene—osteoporosis	0.000348	0.00152	CcSEcCtD
Repaglinide—Pruritus—Ethinyl Estradiol—osteoporosis	0.000347	0.00152	CcSEcCtD
Repaglinide—Palpitations—Estradiol—osteoporosis	0.000346	0.00151	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000345	0.00151	CcSEcCtD
Repaglinide—Nausea—Ibandronate—osteoporosis	0.000344	0.00151	CcSEcCtD
Repaglinide—Constipation—Conjugated Estrogens—osteoporosis	0.000341	0.00149	CcSEcCtD
Repaglinide—Gastrointestinal pain—Zoledronate—osteoporosis	0.000339	0.00148	CcSEcCtD
Repaglinide—Hypertension—Estradiol—osteoporosis	0.000338	0.00148	CcSEcCtD
Repaglinide—Pruritus—Risedronate—osteoporosis	0.000338	0.00148	CcSEcCtD
Repaglinide—Nausea—Calcitriol—osteoporosis	0.000337	0.00147	CcSEcCtD
Repaglinide—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000335	0.00147	CcSEcCtD
Repaglinide—Hypersensitivity—Pamidronate—osteoporosis	0.000334	0.00146	CcSEcCtD
Repaglinide—Chest pain—Estradiol—osteoporosis	0.000333	0.00146	CcSEcCtD
Repaglinide—Arthralgia—Estradiol—osteoporosis	0.000333	0.00146	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000331	0.00145	CcSEcCtD
Repaglinide—Urticaria—Zoledronate—osteoporosis	0.000329	0.00144	CcSEcCtD
Repaglinide—Abdominal pain—Zoledronate—osteoporosis	0.000328	0.00143	CcSEcCtD
Repaglinide—Diarrhoea—Risedronate—osteoporosis	0.000327	0.00143	CcSEcCtD
Repaglinide—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000326	0.00143	CcSEcCtD
Repaglinide—Pruritus—Pamidronate—osteoporosis	0.000321	0.00141	CcSEcCtD
Repaglinide—Oedema—Estradiol—osteoporosis	0.00032	0.0014	CcSEcCtD
Repaglinide—Anaphylactic shock—Estradiol—osteoporosis	0.00032	0.0014	CcSEcCtD
Repaglinide—Urticaria—Conjugated Estrogens—osteoporosis	0.000317	0.00139	CcSEcCtD
Repaglinide—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000316	0.00138	CcSEcCtD
Repaglinide—Vomiting—Ethinyl Estradiol—osteoporosis	0.000311	0.00136	CcSEcCtD
Repaglinide—Diarrhoea—Pamidronate—osteoporosis	0.000311	0.00136	CcSEcCtD
Repaglinide—Skin disorder—Estradiol—osteoporosis	0.00031	0.00136	CcSEcCtD
Repaglinide—Rash—Ethinyl Estradiol—osteoporosis	0.000309	0.00135	CcSEcCtD
Repaglinide—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000309	0.00135	CcSEcCtD
Repaglinide—Headache—Ethinyl Estradiol—osteoporosis	0.000307	0.00134	CcSEcCtD
Repaglinide—Hypersensitivity—Zoledronate—osteoporosis	0.000306	0.00134	CcSEcCtD
Repaglinide—Vomiting—Risedronate—osteoporosis	0.000304	0.00133	CcSEcCtD
Repaglinide—Rash—Risedronate—osteoporosis	0.000301	0.00132	CcSEcCtD
Repaglinide—Dermatitis—Risedronate—osteoporosis	0.000301	0.00132	CcSEcCtD
Repaglinide—Headache—Risedronate—osteoporosis	0.000299	0.00131	CcSEcCtD
Repaglinide—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000294	0.00129	CcSEcCtD
Repaglinide—Pruritus—Zoledronate—osteoporosis	0.000293	0.00128	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000291	0.00127	CcSEcCtD
Repaglinide—Nausea—Ethinyl Estradiol—osteoporosis	0.000291	0.00127	CcSEcCtD
Repaglinide—Vomiting—Pamidronate—osteoporosis	0.000289	0.00126	CcSEcCtD
Repaglinide—Paraesthesia—Estradiol—osteoporosis	0.000287	0.00126	CcSEcCtD
Repaglinide—Rash—Pamidronate—osteoporosis	0.000286	0.00125	CcSEcCtD
Repaglinide—Dermatitis—Pamidronate—osteoporosis	0.000286	0.00125	CcSEcCtD
Repaglinide—Headache—Pamidronate—osteoporosis	0.000284	0.00124	CcSEcCtD
Repaglinide—Diarrhoea—Zoledronate—osteoporosis	0.000284	0.00124	CcSEcCtD
Repaglinide—Nausea—Risedronate—osteoporosis	0.000284	0.00124	CcSEcCtD
Repaglinide—Pruritus—Conjugated Estrogens—osteoporosis	0.000282	0.00124	CcSEcCtD
Repaglinide—Dyspepsia—Estradiol—osteoporosis	0.000281	0.00123	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Estradiol—osteoporosis	0.000276	0.00121	CcSEcCtD
Repaglinide—Constipation—Estradiol—osteoporosis	0.000273	0.0012	CcSEcCtD
Repaglinide—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000273	0.0012	CcSEcCtD
Repaglinide—Nausea—Pamidronate—osteoporosis	0.00027	0.00118	CcSEcCtD
Repaglinide—Vomiting—Zoledronate—osteoporosis	0.000264	0.00115	CcSEcCtD
Repaglinide—Rash—Zoledronate—osteoporosis	0.000261	0.00114	CcSEcCtD
Repaglinide—Gastrointestinal pain—Estradiol—osteoporosis	0.000261	0.00114	CcSEcCtD
Repaglinide—Dermatitis—Zoledronate—osteoporosis	0.000261	0.00114	CcSEcCtD
Repaglinide—Headache—Zoledronate—osteoporosis	0.00026	0.00114	CcSEcCtD
Repaglinide—Vomiting—Conjugated Estrogens—osteoporosis	0.000254	0.00111	CcSEcCtD
Repaglinide—Urticaria—Estradiol—osteoporosis	0.000254	0.00111	CcSEcCtD
Repaglinide—Abdominal pain—Estradiol—osteoporosis	0.000253	0.00111	CcSEcCtD
Repaglinide—Rash—Conjugated Estrogens—osteoporosis	0.000252	0.0011	CcSEcCtD
Repaglinide—Dermatitis—Conjugated Estrogens—osteoporosis	0.000252	0.0011	CcSEcCtD
Repaglinide—Headache—Conjugated Estrogens—osteoporosis	0.00025	0.00109	CcSEcCtD
Repaglinide—Nausea—Zoledronate—osteoporosis	0.000246	0.00108	CcSEcCtD
Repaglinide—Nausea—Conjugated Estrogens—osteoporosis	0.000237	0.00104	CcSEcCtD
Repaglinide—Hypersensitivity—Estradiol—osteoporosis	0.000235	0.00103	CcSEcCtD
Repaglinide—Pruritus—Estradiol—osteoporosis	0.000226	0.000989	CcSEcCtD
Repaglinide—Diarrhoea—Estradiol—osteoporosis	0.000219	0.000957	CcSEcCtD
Repaglinide—Vomiting—Estradiol—osteoporosis	0.000203	0.000889	CcSEcCtD
Repaglinide—Rash—Estradiol—osteoporosis	0.000201	0.000882	CcSEcCtD
Repaglinide—Dermatitis—Estradiol—osteoporosis	0.000201	0.000881	CcSEcCtD
Repaglinide—Headache—Estradiol—osteoporosis	0.0002	0.000876	CcSEcCtD
Repaglinide—Nausea—Estradiol—osteoporosis	0.00019	0.00083	CcSEcCtD
Repaglinide—ABCC8—Metabolism—OXCT1—osteoporosis	0.000129	0.00172	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—CA2—osteoporosis	0.000129	0.00172	CbGpPWpGaD
Repaglinide—ALB—Selenium Micronutrient Network—MTHFR—osteoporosis	0.000128	0.0017	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000128	0.0017	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000128	0.0017	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000127	0.00169	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—RAP1A—osteoporosis	0.000126	0.00168	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—CAP1—osteoporosis	0.000126	0.00168	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—MGLL—osteoporosis	0.000126	0.00168	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PKM—osteoporosis	0.000126	0.00167	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—FDPS—osteoporosis	0.000126	0.00167	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—OXCT1—osteoporosis	0.000126	0.00167	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—CA2—osteoporosis	0.000126	0.00167	CbGpPWpGaD
Repaglinide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000125	0.00166	CbGpPWpGaD
Repaglinide—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000124	0.00164	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—MGLL—osteoporosis	0.000122	0.00162	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000121	0.00161	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000121	0.0016	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PGLS—osteoporosis	0.000119	0.00158	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—GPD2—osteoporosis	0.000119	0.00158	CbGpPWpGaD
Repaglinide—ALB—Vitamin B12 Metabolism—IL1B—osteoporosis	0.000118	0.00156	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—FGA—osteoporosis	0.000115	0.00152	CbGpPWpGaD
Repaglinide—CYP2C8—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000114	0.00151	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—ESR2—osteoporosis	0.000112	0.00148	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—ATIC—osteoporosis	0.000109	0.00145	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PNP—osteoporosis	0.000109	0.00145	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000109	0.00144	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—IDH2—osteoporosis	0.000107	0.00142	CbGpPWpGaD
Repaglinide—ALB—Platelet degranulation—IGF1—osteoporosis	0.000107	0.00141	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—FGB—osteoporosis	0.000104	0.00139	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—RPL24—osteoporosis	0.000104	0.00138	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—IDH2—osteoporosis	0.000104	0.00138	CbGpPWpGaD
Repaglinide—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	0.000103	0.00136	CbGpPWpGaD
Repaglinide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000102	0.00135	CbGpPWpGaD
Repaglinide—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—osteoporosis	0.000101	0.00135	CbGpPWpGaD
Repaglinide—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	0.000101	0.00134	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—CYP27A1—osteoporosis	0.000101	0.00134	CbGpPWpGaD
Repaglinide—CYP2C8—Biological oxidations—CYP19A1—osteoporosis	0.0001	0.00133	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—MGLL—osteoporosis	0.0001	0.00133	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PKM—osteoporosis	9.91e-05	0.00132	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—FDPS—osteoporosis	9.91e-05	0.00132	CbGpPWpGaD
Repaglinide—CYP2C8—Metapathway biotransformation—CYP19A1—osteoporosis	9.91e-05	0.00132	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—ACP5—osteoporosis	9.81e-05	0.0013	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—CYP27A1—osteoporosis	9.78e-05	0.0013	CbGpPWpGaD
Repaglinide—PPARG—Adipogenesis—TGFB1—osteoporosis	9.63e-05	0.00128	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—IL1B—osteoporosis	9.58e-05	0.00127	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—ACP5—osteoporosis	9.51e-05	0.00126	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	9.43e-05	0.00125	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PGLS—osteoporosis	9.39e-05	0.00125	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—GPD2—osteoporosis	9.39e-05	0.00125	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	9.37e-05	0.00124	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—CA2—osteoporosis	9.28e-05	0.00123	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—OXCT1—osteoporosis	9.28e-05	0.00123	CbGpPWpGaD
Repaglinide—ABCC8—Transmembrane transport of small molecules—ADCY5—osteoporosis	9.24e-05	0.00123	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	9.19e-05	0.00122	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PLEK—osteoporosis	9.18e-05	0.00122	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—ANXA2—osteoporosis	9.18e-05	0.00122	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	9.13e-05	0.00121	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—TPI1—osteoporosis	9.12e-05	0.00121	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—MGLL—osteoporosis	9.04e-05	0.0012	CbGpPWpGaD
Repaglinide—PPARG—Adipogenesis—TNF—osteoporosis	8.99e-05	0.00119	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—VDR—osteoporosis	8.86e-05	0.00118	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—TPI1—osteoporosis	8.84e-05	0.00117	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—ATIC—osteoporosis	8.59e-05	0.00114	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PNP—osteoporosis	8.59e-05	0.00114	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—P4HB—osteoporosis	8.57e-05	0.00114	CbGpPWpGaD
Repaglinide—ALB—Vitamin B12 Metabolism—TNF—osteoporosis	8.55e-05	0.00114	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	8.52e-05	0.00113	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—GAPDH—osteoporosis	8.42e-05	0.00112	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—P4HB—osteoporosis	8.31e-05	0.0011	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—RAP1A—osteoporosis	8.2e-05	0.00109	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—GAPDH—osteoporosis	8.16e-05	0.00108	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—RAP1A—osteoporosis	7.95e-05	0.00106	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—ANXA2—osteoporosis	7.94e-05	0.00105	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—TLN1—osteoporosis	7.91e-05	0.00105	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—VCL—osteoporosis	7.8e-05	0.00104	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—IDH2—osteoporosis	7.69e-05	0.00102	CbGpPWpGaD
Repaglinide—ALB—Selenium Micronutrient Network—IL1B—osteoporosis	7.61e-05	0.00101	CbGpPWpGaD
Repaglinide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	7.52e-05	0.000999	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	7.34e-05	0.000975	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—OXCT1—osteoporosis	7.31e-05	0.00097	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CA2—osteoporosis	7.31e-05	0.00097	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	7.3e-05	0.00097	CbGpPWpGaD
Repaglinide—PPARG—Adipogenesis—IL6—osteoporosis	7.25e-05	0.000963	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—CYP27A1—osteoporosis	7.23e-05	0.00096	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—MGLL—osteoporosis	7.12e-05	0.000945	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—ACP5—osteoporosis	7.03e-05	0.000934	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—TNF—osteoporosis	6.95e-05	0.000924	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	6.94e-05	0.000922	CbGpPWpGaD
Repaglinide—ALB—Vitamin B12 Metabolism—IL6—osteoporosis	6.9e-05	0.000916	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—ESR1—osteoporosis	6.77e-05	0.000899	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	6.71e-05	0.000891	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—LEP—osteoporosis	6.68e-05	0.000887	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—ENO1—osteoporosis	6.63e-05	0.00088	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—TPI1—osteoporosis	6.54e-05	0.000868	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PSMA2—osteoporosis	6.53e-05	0.000867	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PSMA5—osteoporosis	6.53e-05	0.000867	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—RAP1A—osteoporosis	6.52e-05	0.000866	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—ENO1—osteoporosis	6.43e-05	0.000853	CbGpPWpGaD
Repaglinide—ALB—Platelet degranulation—TGFB1—osteoporosis	6.39e-05	0.000848	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PSMA5—osteoporosis	6.33e-05	0.000841	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PSMA2—osteoporosis	6.33e-05	0.000841	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	6.24e-05	0.000829	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	6.21e-05	0.000824	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—P4HB—osteoporosis	6.15e-05	0.000816	CbGpPWpGaD
Repaglinide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	6.1e-05	0.00081	CbGpPWpGaD
Repaglinide—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	6.08e-05	0.000808	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—IDH2—osteoporosis	6.05e-05	0.000804	CbGpPWpGaD
Repaglinide—CYP2C8—Biological oxidations—POMC—osteoporosis	6.04e-05	0.000802	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—GAPDH—osteoporosis	6.03e-05	0.000801	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—PSMA2—osteoporosis	6.02e-05	0.000799	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—PSMA5—osteoporosis	6.02e-05	0.000799	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—FGA—osteoporosis	5.91e-05	0.000785	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—RAP1A—osteoporosis	5.87e-05	0.00078	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—FDPS—osteoporosis	5.69e-05	0.000756	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PKM—osteoporosis	5.69e-05	0.000756	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CYP27A1—osteoporosis	5.69e-05	0.000756	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PKM—osteoporosis	5.66e-05	0.000752	CbGpPWpGaD
Repaglinide—ALB—Metabolism—FDPS—osteoporosis	5.66e-05	0.000752	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—IL6—osteoporosis	5.61e-05	0.000745	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—IL6R—osteoporosis	5.6e-05	0.000743	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—ACP5—osteoporosis	5.54e-05	0.000735	CbGpPWpGaD
Repaglinide—ALB—Selenium Micronutrient Network—TNF—osteoporosis	5.53e-05	0.000734	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	5.47e-05	0.000726	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PGLS—osteoporosis	5.4e-05	0.000717	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GPD2—osteoporosis	5.4e-05	0.000717	CbGpPWpGaD
Repaglinide—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	5.39e-05	0.000716	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—FGB—osteoporosis	5.38e-05	0.000714	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—ESR2—osteoporosis	5.38e-05	0.000714	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PGLS—osteoporosis	5.37e-05	0.000713	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GPD2—osteoporosis	5.37e-05	0.000713	CbGpPWpGaD
Repaglinide—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	5.32e-05	0.000706	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—CYP19A1—osteoporosis	5.3e-05	0.000704	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—ADCY5—osteoporosis	5.22e-05	0.000693	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—TPI1—osteoporosis	5.15e-05	0.000683	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—CYP19A1—osteoporosis	5.14e-05	0.000682	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—POMC—osteoporosis	5.12e-05	0.00068	CbGpPWpGaD
Repaglinide—PPARG—Circadian rythm related genes—IL6—osteoporosis	5.12e-05	0.00068	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ATIC—osteoporosis	4.94e-05	0.000656	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PNP—osteoporosis	4.94e-05	0.000656	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ATIC—osteoporosis	4.91e-05	0.000652	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PNP—osteoporosis	4.91e-05	0.000652	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—P4HB—osteoporosis	4.84e-05	0.000643	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—GAPDH—osteoporosis	4.75e-05	0.000631	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—ENO1—osteoporosis	4.75e-05	0.000631	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—IGF1—osteoporosis	4.72e-05	0.000627	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PSMA2—osteoporosis	4.68e-05	0.000621	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PSMA5—osteoporosis	4.68e-05	0.000621	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—RAP1A—osteoporosis	4.63e-05	0.000614	CbGpPWpGaD
Repaglinide—ALB—Selenium Micronutrient Network—IL6—osteoporosis	4.46e-05	0.000592	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—ADCY5—osteoporosis	4.33e-05	0.000575	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—GPX1—osteoporosis	4.31e-05	0.000573	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—VDR—osteoporosis	4.27e-05	0.000567	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CA2—osteoporosis	4.2e-05	0.000557	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—OXCT1—osteoporosis	4.2e-05	0.000557	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—ADCY5—osteoporosis	4.2e-05	0.000557	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—GPX1—osteoporosis	4.18e-05	0.000555	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CA2—osteoporosis	4.17e-05	0.000554	CbGpPWpGaD
Repaglinide—ALB—Metabolism—OXCT1—osteoporosis	4.17e-05	0.000554	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—MGLL—osteoporosis	4.09e-05	0.000543	CbGpPWpGaD
Repaglinide—ALB—Metabolism—MGLL—osteoporosis	4.07e-05	0.00054	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	4.03e-05	0.000536	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—MTHFR—osteoporosis	3.98e-05	0.000529	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—MTHFR—osteoporosis	3.86e-05	0.000513	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.86e-05	0.000512	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.84e-05	0.000509	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—CYP19A1—osteoporosis	3.8e-05	0.000504	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—ENO1—osteoporosis	3.74e-05	0.000497	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PSMA2—osteoporosis	3.68e-05	0.000489	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PSMA5—osteoporosis	3.68e-05	0.000489	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—MYC—osteoporosis	3.52e-05	0.000468	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—IDH2—osteoporosis	3.48e-05	0.000462	CbGpPWpGaD
Repaglinide—ALB—Metabolism—IDH2—osteoporosis	3.46e-05	0.000459	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—TGFB1—osteoporosis	3.31e-05	0.000439	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CYP27A1—osteoporosis	3.27e-05	0.000434	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—ESR1—osteoporosis	3.26e-05	0.000433	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CYP27A1—osteoporosis	3.25e-05	0.000432	CbGpPWpGaD
Repaglinide—CYP3A4—Biological oxidations—POMC—osteoporosis	3.24e-05	0.00043	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—POMC—osteoporosis	3.18e-05	0.000423	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ACP5—osteoporosis	3.18e-05	0.000422	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ACP5—osteoporosis	3.16e-05	0.00042	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.14e-05	0.000417	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.12e-05	0.000415	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—ADCY5—osteoporosis	3.1e-05	0.000412	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—GPX1—osteoporosis	3.09e-05	0.000411	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—TNF—osteoporosis	3.09e-05	0.00041	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—POMC—osteoporosis	3.09e-05	0.00041	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PKM—osteoporosis	3.06e-05	0.000406	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—FDPS—osteoporosis	3.06e-05	0.000406	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CYP19A1—osteoporosis	2.99e-05	0.000397	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.98e-05	0.000396	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—TPI1—osteoporosis	2.96e-05	0.000393	CbGpPWpGaD
Repaglinide—ALB—Metabolism—TPI1—osteoporosis	2.94e-05	0.000391	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GPD2—osteoporosis	2.9e-05	0.000385	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PGLS—osteoporosis	2.9e-05	0.000385	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—MTHFR—osteoporosis	2.85e-05	0.000379	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	2.83e-05	0.000376	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—P4HB—osteoporosis	2.78e-05	0.000369	CbGpPWpGaD
Repaglinide—ALB—Metabolism—P4HB—osteoporosis	2.76e-05	0.000367	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GAPDH—osteoporosis	2.73e-05	0.000362	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GAPDH—osteoporosis	2.71e-05	0.00036	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—RAP1A—osteoporosis	2.66e-05	0.000353	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PNP—osteoporosis	2.65e-05	0.000352	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ATIC—osteoporosis	2.65e-05	0.000352	CbGpPWpGaD
Repaglinide—ALB—Metabolism—RAP1A—osteoporosis	2.64e-05	0.000351	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—IL6—osteoporosis	2.49e-05	0.000331	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—ADCY5—osteoporosis	2.44e-05	0.000324	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—IGF1—osteoporosis	2.44e-05	0.000323	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—GPX1—osteoporosis	2.43e-05	0.000323	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.32e-05	0.000308	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.31e-05	0.000306	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—POMC—osteoporosis	2.28e-05	0.000303	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—OXCT1—osteoporosis	2.25e-05	0.000299	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CA2—osteoporosis	2.25e-05	0.000299	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—MTHFR—osteoporosis	2.25e-05	0.000298	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—MGLL—osteoporosis	2.2e-05	0.000292	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ENO1—osteoporosis	2.15e-05	0.000285	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ENO1—osteoporosis	2.14e-05	0.000284	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PSMA2—osteoporosis	2.12e-05	0.000281	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PSMA5—osteoporosis	2.12e-05	0.000281	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PSMA2—osteoporosis	2.11e-05	0.00028	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PSMA5—osteoporosis	2.11e-05	0.00028	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—IDH2—osteoporosis	1.87e-05	0.000248	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—POMC—osteoporosis	1.8e-05	0.000239	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.76e-05	0.000233	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CYP19A1—osteoporosis	1.72e-05	0.000228	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CYP19A1—osteoporosis	1.71e-05	0.000227	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ACP5—osteoporosis	1.71e-05	0.000227	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—MYC—osteoporosis	1.7e-05	0.000225	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—TPI1—osteoporosis	1.59e-05	0.000211	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—P4HB—osteoporosis	1.49e-05	0.000198	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GAPDH—osteoporosis	1.46e-05	0.000195	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—TGFB1—osteoporosis	1.46e-05	0.000194	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—RAP1A—osteoporosis	1.43e-05	0.000189	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ADCY5—osteoporosis	1.4e-05	0.000186	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GPX1—osteoporosis	1.4e-05	0.000186	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ADCY5—osteoporosis	1.4e-05	0.000185	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GPX1—osteoporosis	1.39e-05	0.000185	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—MTHFR—osteoporosis	1.29e-05	0.000171	CbGpPWpGaD
Repaglinide—ALB—Metabolism—MTHFR—osteoporosis	1.28e-05	0.00017	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ENO1—osteoporosis	1.15e-05	0.000153	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PSMA5—osteoporosis	1.14e-05	0.000151	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PSMA2—osteoporosis	1.14e-05	0.000151	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—POMC—osteoporosis	1.03e-05	0.000137	CbGpPWpGaD
Repaglinide—ALB—Metabolism—POMC—osteoporosis	1.03e-05	0.000136	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CYP19A1—osteoporosis	9.22e-06	0.000122	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ADCY5—osteoporosis	7.53e-06	0.0001	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GPX1—osteoporosis	7.51e-06	9.97e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—MTHFR—osteoporosis	6.93e-06	9.2e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—POMC—osteoporosis	5.54e-06	7.36e-05	CbGpPWpGaD
